These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 32156509)

  • 21. Protective anti-Pseudomonas aeruginosa humoral and cellular mucosal immunity by AdC7-mediated expression of the P. aeruginosa protein OprF.
    Krause A; Whu WZ; Xu Y; Joh J; Crystal RG; Worgall S
    Vaccine; 2011 Mar; 29(11):2131-9. PubMed ID: 21215829
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenic reactivity of recombinant PKF and AbOmpA proteins as serum resistance factors against sepsis of Acinetobacter baumannii.
    Bolourchi N; Shahcheraghi F; Shirazi AS; Janani A; Bahrami F; Badmasti F
    Microb Pathog; 2019 Jun; 131():9-14. PubMed ID: 30930220
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Protection against experimental Pseudomonas aeruginosa infection by recombinant P. aeruginosa lipoprotein I expressed in Escherichia coli.
    Finke M; Duchêne M; Eckhardt A; Domdey H; von Specht BU
    Infect Immun; 1990 Jul; 58(7):2241-4. PubMed ID: 2114360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Protection of immunocompromised mice against lethal infection with Pseudomonas aeruginosa by active or passive immunization with recombinant P. aeruginosa outer membrane protein F and outer membrane protein I fusion proteins.
    von Specht BU; Knapp B; Muth G; Bröker M; Hungerer KD; Diehl KD; Massarrat K; Seemann A; Domdey H
    Infect Immun; 1995 May; 63(5):1855-62. PubMed ID: 7729895
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multicomponent Pseudomonas aeruginosa Vaccines Eliciting Th17 Cells and Functional Antibody Responses Confer Enhanced Protection against Experimental Acute Pneumonia in Mice.
    Shaikh MOF; Schaefers MM; Merakou C; DiBlasi M; Bonney S; Liao T; Zurakowski D; Kehl M; Tabor DE; DiGiandomenico A; Priebe GP
    Infect Immun; 2022 Oct; 90(10):e0020322. PubMed ID: 36069593
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Safety and immunogenicity of an intranasal Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
    Larbig M; Mansouri E; Freihorst J; Tümmler B; Köhler G; Domdey H; Knapp B; Hungerer KD; Hundt E; Gabelsberger J; von Specht BU
    Vaccine; 2001 Mar; 19(17-19):2291-7. PubMed ID: 11257350
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Protection against P. aeruginosa with an adenovirus vector containing an OprF epitope in the capsid.
    Worgall S; Krause A; Rivara M; Hee KK; Vintayen EV; Hackett NR; Roelvink PW; Bruder JT; Wickham TJ; Kovesdi I; Crystal RG
    J Clin Invest; 2005 May; 115(5):1281-9. PubMed ID: 15841217
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A hybrid outer membrane protein antigen for vaccination against Pseudomonas aeruginosa.
    Gabelsberger J; Knapp B; Bauersachs S; Enz UI; von Specht BU; Domdey H
    Behring Inst Mitt; 1997 Feb; (98):302-14. PubMed ID: 9382754
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immunoprotective potential of in silico predicted Acinetobacter baumannii outer membrane nuclease, NucAb.
    Garg N; Singh R; Shukla G; Capalash N; Sharma P
    Int J Med Microbiol; 2016 Jan; 306(1):1-9. PubMed ID: 26614015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Recombinant OprF-OprI as a vaccine against Pseudomonas aeruginosa infections.
    Baumann U; Mansouri E; von Specht BU
    Vaccine; 2004 Feb; 22(7):840-7. PubMed ID: 15040936
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In silico design of an immunogen against Acinetobacter baumannii based on a novel model for native structure of Outer membrane protein A.
    Jahangiri A; Rasooli I; Owlia P; Fooladi AA; Salimian J
    Microb Pathog; 2017 Apr; 105():201-210. PubMed ID: 28242426
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Protection against Pseudomonas aeruginosa lung infection in mice by recombinant OprF-pulsed dendritic cell immunization.
    Peluso L; de Luca C; Bozza S; Leonardi A; Giovannini G; Lavorgna A; De Rosa G; Mascolo M; Ortega De Luna L; Catania MR; Romani L; Rossano F
    BMC Microbiol; 2010 Jan; 10():9. PubMed ID: 20070893
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Outer membrane proteins of Pseudomonas aeruginosa as vaccine candidates.
    von Specht B; Knapp B; Hungerer K; Lücking C; Schmitt A; Domdey H
    J Biotechnol; 1996 Jan; 44(1-3):145-53. PubMed ID: 8717398
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chimeric animal and plant viruses expressing epitopes of outer membrane protein F as a combined vaccine against Pseudomonas aeruginosa lung infection.
    Gilleland HE; Gilleland LB; Staczek J; Harty RN; García-Sastre A; Palese P; Brennan FR; Hamilton WD; Bendahmane M; Beachy RN
    FEMS Immunol Med Microbiol; 2000 Apr; 27(4):291-7. PubMed ID: 10727884
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recombinant protein composed of Pseudomonas exotoxin A, outer membrane proteins I and F as vaccine against P. aeruginosa infection.
    Chen TY; Shang HF; Chen TL; Lin CP; Hui CF; Hwang J
    Appl Microbiol Biotechnol; 1999 Oct; 52(4):524-33. PubMed ID: 10570800
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Protection against Acinetobacter baumannii infection via its functional deprivation of biofilm associated protein (Bap).
    Fattahian Y; Rasooli I; Mousavi Gargari SL; Rahbar MR; Darvish Alipour Astaneh S; Amani J
    Microb Pathog; 2011 Dec; 51(6):402-6. PubMed ID: 21946278
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Safety and immunogenicity of a Pseudomonas aeruginosa hybrid outer membrane protein F-I vaccine in human volunteers.
    Mansouri E; Gabelsberger J; Knapp B; Hundt E; Lenz U; Hungerer KD; Gilleland HE; Staczek J; Domdey H; von Specht BU
    Infect Immun; 1999 Mar; 67(3):1461-70. PubMed ID: 10024596
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunization with a 22-kDa outer membrane protein elicits protective immunity to multidrug-resistant Acinetobacter baumannii.
    Huang W; Yao Y; Wang S; Xia Y; Yang X; Long Q; Sun W; Liu C; Li Y; Chu X; Bai H; Yao Y; Ma Y
    Sci Rep; 2016 Feb; 6():20724. PubMed ID: 26853590
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Study of immunogenic properties of recombinant outer membrane proteins F and L from Pseudomonas aeruginosa].
    Kaloshin AA; Zlygostev SA; Gatypova EV; Mikhaĭlova NA
    Zh Mikrobiol Epidemiol Immunobiol; 2008; (5):76-9. PubMed ID: 19004286
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of an anti-adhesive vaccine for Pseudomonas aeruginosa targeting the C-terminal region of the pilin structural protein.
    Sheth HB; Glasier LM; Ellert NW; Cachia P; Kohn W; Lee KK; Paranchych W; Hodges RS; Irvin RT
    Biomed Pept Proteins Nucleic Acids; 1995; 1(3):141-8. PubMed ID: 9346845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.